94 related articles for article (PubMed ID: 21574303)
1. [Mediator, the police of the medication in question].
Mauduit L
Soins; 2011 Apr; (754):6. PubMed ID: 21574303
[No Abstract] [Full Text] [Related]
2. [What were the indications for the Mediator in 1979?].
Nau JY
Rev Med Suisse; 2011 Feb; 7(281):374-5. PubMed ID: 21416722
[No Abstract] [Full Text] [Related]
3. Mediator: who's to blame?
Waller P; Evans S
Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
[No Abstract] [Full Text] [Related]
4. Mediator scandal rocks French medical community.
Mullard A
Lancet; 2011 Mar; 377(9769):890-2. PubMed ID: 21409784
[No Abstract] [Full Text] [Related]
5. Mediator: who's to blame?
Vincent L; Guardiola B; Tsouderos Y; Canet E
Lancet; 2011 Jun; 377(9782):2003. PubMed ID: 21665033
[No Abstract] [Full Text] [Related]
6. [The French are wary of their drugs].
Nau JY
Rev Med Suisse; 2011 May; 7(296):1170-1. PubMed ID: 21728251
[No Abstract] [Full Text] [Related]
7. [Benfluorex (Mediator®), our vigilance in question].
Frachon I
Presse Med; 2011 May; 40(5):459-61. PubMed ID: 21470816
[No Abstract] [Full Text] [Related]
8. Valvular heart disease associated with benfluorex.
Gueffet JP; Piriou N; Trochu JN
Arch Cardiovasc Dis; 2010 May; 103(5):342-3. PubMed ID: 20619246
[No Abstract] [Full Text] [Related]
9. How can benfluorex-related heart valve disease be identified by echocardiography?
Tribouilloy C; Rusinaru D; Andréjak M
Arch Cardiovasc Dis; 2011 Oct; 104(10):489-92. PubMed ID: 22044700
[No Abstract] [Full Text] [Related]
10. Drug-induced valve disease and considerations of benefit versus risk.
Borer JS
Eur Heart J; 2013 Dec; 34(46):3535-7. PubMed ID: 24042062
[No Abstract] [Full Text] [Related]
11. Top adviser at the European Medicines Agency quits suddenly.
Benkimoun P
BMJ; 2012 Apr; 344():e2641. PubMed ID: 22496308
[No Abstract] [Full Text] [Related]
12. Lessons from the Mediator scandal.
Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
[No Abstract] [Full Text] [Related]
13. Pulmonary arterial hypertension and benfluorex: 5 case reports.
Bondon-Guitton E; Prévôt G; Didier A; Montastruc JL
Therapie; 2011; 66(2):135-8. PubMed ID: 21635861
[TBL] [Abstract][Full Text] [Related]
14. Mediator: who's to blame?
Braillon A
Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
[No Abstract] [Full Text] [Related]
15. Benfluorex: EU marketing authorisation finally withdrawn.
Prescrire Int; 2010 Oct; 19(109):206. PubMed ID: 21188803
[TBL] [Abstract][Full Text] [Related]
16. Benfluorex: how many deaths?
Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
[No Abstract] [Full Text] [Related]
17. Benfluorex: increasing reports of valve disorders.
Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
[TBL] [Abstract][Full Text] [Related]
18. Appetite suppressant was probably responsible for 1300 deaths, study shows.
Benkimoun P
BMJ; 2012 Feb; 344():e996. PubMed ID: 22323511
[No Abstract] [Full Text] [Related]
19. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
[No Abstract] [Full Text] [Related]
20. European legislators tighten rules on drug safety.
Watson R
BMJ; 2012 Sep; 345():e6260. PubMed ID: 22991010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
